- Meeting abstract
- Open Access
Therobotat the sideof the nurse: present situation and prospects
© Mastro et al. 2015
- Published: 24 September 2015
- Medical Error
- Neonatal Intensive Care Unit
- Computerize System
- Therapeutic Process
- Successive Phasis
Patient safetyis a priority worldwide. According to the WHO medical errors involve 1 in 10 patients, providing damageor injury, including standing up to cause death . Even the nurses can not refrain from protecting the patient as regards security, as explained in Art. 29 of the Code of ethics of nurses . The complexity of the Neonatal Intensive Care Unit (NICU), the vulnerability of the neonatal population and the use of drugs “off-label” increase the risk of medical errors [3, 4].
The literature reports that the risks of medical errors are related to the preparation of injectable drugs, quantified, insome cases, up to26.90% (?) of the doses somministrate .
A new robotic technology, called ivSTATION®(Health-Robotics) and specifically developed for the preparation of injectable ready to administration, was introduced in our NICU to simplify the therapeutic processin the preparation stage, to optimize resources and times and especially to enhance the security. ivSTATION® is able to reconstitute powdered drugs, to obtain dilutions specifications, to verify doses prepared before making them available and to provide them with a label containing all the information required. The therapy is prepared in an aseptic environment ISO 5equipped with HEPA filters 14. The unit is equipped with UV lamps that contribute to the microbiological control overnight. ivSTATION® provides total trace ability of information about each preparation produced, making it possible to extract all the time both data specific to a single preparation and general data to be used for statistical analysis. Once the drug is prepared, it appears on the medical record through a symbol, allowing the nurse to proceed with the implementation of the successive phases of the therapeutic process, in strict observance of safety rules. The integration of the robot in the preparation of the therapies, associated with the system of the therapeutic process with the computerized system “bar code”, allows a considerable decrease of the risk in both the preparation phase of identification of the patient, which are known to those where the errors are hardly detectable [6, 7].
This technology is a useful tool for limiting the error and the niatrogenic clinical risk associated with medical therapy. The nurse, in charge of patients, has the opportunity, with the use of this technology, to spend more timenursing careproper.
- World Health Organization: WHO launches ‘Nine patient safety solutions. 2007, [http://www.who.int/mediacentre/news/releases/2007/pr22/en/index.html]Google Scholar
- 2009Google Scholar
- Samra HA, McGrath JM, Rollins W: Patient Safety in the NICU: a comprehensive review. J Perinat Neonat Nurs. 2011, 25 (2): 123-132. 10.1097/JPN.0b013e31821693b2.View ArticleGoogle Scholar
- Frattarelli DA, Galinkin JL, Green TP, Johnson TD, Neville KA, Paul IM, Van Den Anker JN, American Academy of Pediatrics Committee on Drugs: Off-Label Use of Drugs in Children. Pediatrics. 2014, 133 (3): 563-567.View ArticlePubMedGoogle Scholar
- Schneider MP, Cotting J, Pannatier A: Evaluation of nurses errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci. 1998, 20 (4): 178-182. 10.1023/A:1012087727393.View ArticlePubMedGoogle Scholar
- Pacheco Ramos Mde L, Arenaza Peña AE, Santiago Pérez A, Bilbao Gómez-Martino C, Zamora Barrios MD, Arias Fernández ML: Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service. Farm Hosp. 2015, 39 (3): 137-146.PubMedGoogle Scholar
- Poon EG, Keohane CA, Yoon CS, Ditmore M, Bane A, Levtzion-Korach O, Moniz T, Rothschild JM, Kachalia AB, Hayes J, Churchill WW, Lipsitz S, Whittemore AD, Bates DW, Gandhi TK: Effect of bar-codetechnology on the safety of medication administration. N Engl J Med. 2010, 362: 1698-1707. 10.1056/NEJMsa0907115.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.